Cargando…

Point-of-care C-reactive protein testing service for respiratory tract infections in community pharmacy: a qualitative study of service uptake and experience of pharmacists

Background Targeted interventions in community pharmacies, such as point-of-care C-reactive protein testing, could reduce inappropriate antimicrobial consumption in patients presenting with symptoms of respiratory tract infections, although data regarding Australian pharmacists’ perspectives on its...

Descripción completa

Detalles Bibliográficos
Autores principales: Czarniak, Petra, Chalmers, Leanne, Hughes, Jeffery, Iacob, Rebecca, Lee, Ya Ping, Parsons, Kiran, Parsons, Richard, Sunderland, Bruce, Sim, Tin Fei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8794609/
https://www.ncbi.nlm.nih.gov/pubmed/35088232
http://dx.doi.org/10.1007/s11096-021-01368-2
_version_ 1784640851359563776
author Czarniak, Petra
Chalmers, Leanne
Hughes, Jeffery
Iacob, Rebecca
Lee, Ya Ping
Parsons, Kiran
Parsons, Richard
Sunderland, Bruce
Sim, Tin Fei
author_facet Czarniak, Petra
Chalmers, Leanne
Hughes, Jeffery
Iacob, Rebecca
Lee, Ya Ping
Parsons, Kiran
Parsons, Richard
Sunderland, Bruce
Sim, Tin Fei
author_sort Czarniak, Petra
collection PubMed
description Background Targeted interventions in community pharmacies, such as point-of-care C-reactive protein testing, could reduce inappropriate antimicrobial consumption in patients presenting with symptoms of respiratory tract infections, although data regarding Australian pharmacists’ perspectives on its provision are limited. Aim To explore pharmacists’ experiences and perspectives of point-of-care C-reactive protein testing, including barriers and facilitators, influencing service provision and uptake. Method A point-of-care C-reactive protein testing service for patients presenting with respiratory tract infection symptoms was trialled in five purposively selected community pharmacies in metropolitan Western Australia. Two pharmacists from each pharmacy participated in one-to-one semi-structured telephone interviews, regarding pharmacist demographics, pharmacy characteristics, experience with the point-of-care C-reactive protein service and training/resources. Interviews were audio-recorded and transcribed. Data were imported into NVivo for thematic analysis. Results Interview durations ranged from 28.2 to 60.2 min (mean: 50.7 ± 10.2 min). Of the five themes which emerged, participants reported the point-of-care C-reactive protein testing was simple, fast, reliable and accurate, assisted their clinical decision-making and contributed to antimicrobial stewardship. A major factor facilitating service provision and uptake by consumers was the accessibility and credibility of pharmacists. Barriers included time constraints and heavy documentation. Participants believed there was a public demand for the service. Conclusion Given the global antimicrobial resistance crisis, pharmacists have an important role in minimising the inappropriate use of antimicrobials. The point-of-care C-reactive protein service was readily accepted by the public when offered. However, ensuring efficient service delivery and adequate remuneration are essential for its successful implementation.
format Online
Article
Text
id pubmed-8794609
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-87946092022-01-28 Point-of-care C-reactive protein testing service for respiratory tract infections in community pharmacy: a qualitative study of service uptake and experience of pharmacists Czarniak, Petra Chalmers, Leanne Hughes, Jeffery Iacob, Rebecca Lee, Ya Ping Parsons, Kiran Parsons, Richard Sunderland, Bruce Sim, Tin Fei Int J Clin Pharm Research Article Background Targeted interventions in community pharmacies, such as point-of-care C-reactive protein testing, could reduce inappropriate antimicrobial consumption in patients presenting with symptoms of respiratory tract infections, although data regarding Australian pharmacists’ perspectives on its provision are limited. Aim To explore pharmacists’ experiences and perspectives of point-of-care C-reactive protein testing, including barriers and facilitators, influencing service provision and uptake. Method A point-of-care C-reactive protein testing service for patients presenting with respiratory tract infection symptoms was trialled in five purposively selected community pharmacies in metropolitan Western Australia. Two pharmacists from each pharmacy participated in one-to-one semi-structured telephone interviews, regarding pharmacist demographics, pharmacy characteristics, experience with the point-of-care C-reactive protein service and training/resources. Interviews were audio-recorded and transcribed. Data were imported into NVivo for thematic analysis. Results Interview durations ranged from 28.2 to 60.2 min (mean: 50.7 ± 10.2 min). Of the five themes which emerged, participants reported the point-of-care C-reactive protein testing was simple, fast, reliable and accurate, assisted their clinical decision-making and contributed to antimicrobial stewardship. A major factor facilitating service provision and uptake by consumers was the accessibility and credibility of pharmacists. Barriers included time constraints and heavy documentation. Participants believed there was a public demand for the service. Conclusion Given the global antimicrobial resistance crisis, pharmacists have an important role in minimising the inappropriate use of antimicrobials. The point-of-care C-reactive protein service was readily accepted by the public when offered. However, ensuring efficient service delivery and adequate remuneration are essential for its successful implementation. Springer International Publishing 2022-01-28 2022 /pmc/articles/PMC8794609/ /pubmed/35088232 http://dx.doi.org/10.1007/s11096-021-01368-2 Text en © The Author(s), under exclusive licence to Springer Nature Switzerland AG 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Research Article
Czarniak, Petra
Chalmers, Leanne
Hughes, Jeffery
Iacob, Rebecca
Lee, Ya Ping
Parsons, Kiran
Parsons, Richard
Sunderland, Bruce
Sim, Tin Fei
Point-of-care C-reactive protein testing service for respiratory tract infections in community pharmacy: a qualitative study of service uptake and experience of pharmacists
title Point-of-care C-reactive protein testing service for respiratory tract infections in community pharmacy: a qualitative study of service uptake and experience of pharmacists
title_full Point-of-care C-reactive protein testing service for respiratory tract infections in community pharmacy: a qualitative study of service uptake and experience of pharmacists
title_fullStr Point-of-care C-reactive protein testing service for respiratory tract infections in community pharmacy: a qualitative study of service uptake and experience of pharmacists
title_full_unstemmed Point-of-care C-reactive protein testing service for respiratory tract infections in community pharmacy: a qualitative study of service uptake and experience of pharmacists
title_short Point-of-care C-reactive protein testing service for respiratory tract infections in community pharmacy: a qualitative study of service uptake and experience of pharmacists
title_sort point-of-care c-reactive protein testing service for respiratory tract infections in community pharmacy: a qualitative study of service uptake and experience of pharmacists
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8794609/
https://www.ncbi.nlm.nih.gov/pubmed/35088232
http://dx.doi.org/10.1007/s11096-021-01368-2
work_keys_str_mv AT czarniakpetra pointofcarecreactiveproteintestingserviceforrespiratorytractinfectionsincommunitypharmacyaqualitativestudyofserviceuptakeandexperienceofpharmacists
AT chalmersleanne pointofcarecreactiveproteintestingserviceforrespiratorytractinfectionsincommunitypharmacyaqualitativestudyofserviceuptakeandexperienceofpharmacists
AT hughesjeffery pointofcarecreactiveproteintestingserviceforrespiratorytractinfectionsincommunitypharmacyaqualitativestudyofserviceuptakeandexperienceofpharmacists
AT iacobrebecca pointofcarecreactiveproteintestingserviceforrespiratorytractinfectionsincommunitypharmacyaqualitativestudyofserviceuptakeandexperienceofpharmacists
AT leeyaping pointofcarecreactiveproteintestingserviceforrespiratorytractinfectionsincommunitypharmacyaqualitativestudyofserviceuptakeandexperienceofpharmacists
AT parsonskiran pointofcarecreactiveproteintestingserviceforrespiratorytractinfectionsincommunitypharmacyaqualitativestudyofserviceuptakeandexperienceofpharmacists
AT parsonsrichard pointofcarecreactiveproteintestingserviceforrespiratorytractinfectionsincommunitypharmacyaqualitativestudyofserviceuptakeandexperienceofpharmacists
AT sunderlandbruce pointofcarecreactiveproteintestingserviceforrespiratorytractinfectionsincommunitypharmacyaqualitativestudyofserviceuptakeandexperienceofpharmacists
AT simtinfei pointofcarecreactiveproteintestingserviceforrespiratorytractinfectionsincommunitypharmacyaqualitativestudyofserviceuptakeandexperienceofpharmacists